Cargando…
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Preclinical studies highlighted potential therapeutic applications of aspirin and statins as anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the role of aspirin and statins in the chemoprevention of hepatocellular carcinoma (HCC). However, observational data is...
Autores principales: | Goh, Myung Ji, Sinn, Dong Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293618/ https://www.ncbi.nlm.nih.gov/pubmed/35021597 http://dx.doi.org/10.3350/cmh.2021.0366 |
Ejemplares similares
-
Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022) -
13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS
por: Al-Yaman, Wael A., et al.
Publicado: (2021) -
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
por: Goh, Myung Ji, et al.
Publicado: (2023) -
Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma
por: Shimizu, Masahito, et al.
Publicado: (2015) -
Uncovering the mechanism of action of aspirin in HCC chemoprevention
por: Roehlen, Natascha, et al.
Publicado: (2019)